Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Viemed Healthcare ( (VMD) ) has shared an announcement.
Viemed Healthcare, Inc., a national provider of technology-enabled, home-based healthcare solutions focused on respiratory, chronic care, and women’s health, reported record financial results for the fourth quarter and full year ended December 31, 2025. The company’s home-care model combines clinical support with technology-enabled services and operates across a broad U.S. payor network, supporting growing patient counts in ventilator and sleep-related therapies.
For the quarter ended December 31, 2025, Viemed posted record net revenue of $76.2 million, up 26% year over year, and full-year 2025 net revenue of $270.3 million, up 21%, aided by strong organic growth and contributions from the Lehan’s Medical Equipment acquisition. Net income attributable to Viemed reached $5.6 million for the quarter and $14.9 million for the year, marking a 33% annual increase and the company’s ninth consecutive year of positive net income.
Adjusted EBITDA climbed to $18.2 million for the quarter and a record $61.4 million for 2025, while operating cash flow rose to $51.9 million and free cash flow more than doubled to $28.1 million versus 2024. Patient volumes expanded, with ventilator patients up 4% to 12,259, PAP therapy patients up 62% to 34,528, and sleep resupply patients up 49% to 36,561 as of year-end 2025, underscoring rising demand for its chronic care services.
As of December 31, 2025, Viemed held $13.5 million in cash, $7.4 million in working capital, $11.3 million in long-term debt, and $46 million of available credit capacity, supporting further investment and capital deployment. On March 4, 2026, the board authorized a share repurchase program on Nasdaq for up to 1,930,131 common shares, signaling management’s confidence in cash flow durability and providing a new lever for returning capital to shareholders.
Looking ahead to 2026, Viemed issued guidance calling for net revenue between $310 million and $320 million and adjusted EBITDA between $65 million and $69 million, with net capital expenditures expected at 10% to 11.5% of net revenue. Executives said the company enters 2026 with strong momentum, emphasizing operational excellence, innovation, and disciplined capital allocation as it expands chronic care and maternal health offerings and pursues additional strategic growth opportunities.
The most recent analyst rating on (VMD) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Viemed Healthcare stock, see the VMD Stock Forecast page.
Spark’s Take on VMD Stock
According to Spark, TipRanks’ AI Analyst, VMD is a Outperform.
Viemed Healthcare’s overall stock score reflects its strong financial health and positive earnings call sentiment, driven by robust revenue growth and strategic expansions. While technical indicators and valuation suggest moderate performance, the company’s strategic initiatives and share repurchase program enhance its long-term growth prospects.
To see Spark’s full report on VMD stock, click here.
More about Viemed Healthcare
Viemed Healthcare, Inc. is a U.S.-based provider of home medical equipment and post-acute healthcare services, with a focus on respiratory, chronic care, and women’s health products and services. The company delivers care in the home through high-touch clinical support and technology-enabled services, including therapy, education, and counseling for patients with chronic conditions.
Viemed operates a nationwide payor network and targets patients requiring long-term respiratory support and related chronic disease management, as well as expanding maternal health offerings. Its model emphasizes efficient, high-quality care and leverages acquisitions, such as Lehan’s Medical Equipment, to deepen market penetration and broaden its platform of home-based healthcare solutions.
Average Trading Volume: 162,814
Technical Sentiment Signal: Buy
Current Market Cap: $340.3M
See more insights into VMD stock on TipRanks’ Stock Analysis page.